Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
27 April 2022Website:
http://www.tenonmed.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
after hours | Thu, 21 Nov 2024 00:03:50 GMTDividend
Analysts recommendations
Institutional Ownership
TNON Latest News
Tenon Medical, Inc. (NASDAQ:TNON ) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Company Participants Steven Foster - President & CEO Kevin Williamson - CFO Conference Call Participants Anthony Vendetti - Maxim Group Operator Greetings, and welcome to the Tenon Medical Third Quarter 2024 Financial Results and Corporate Update Conference Call. As a reminder, this call is being recorded.
LOS GATOS, CA / ACCESSWIRE / September 4, 2024 / Tenon Medical, Inc. ("Tenon" or the "Company") (NASDAQ:TNON), a company transforming care for patients suffering with certain sacroiliac joint disorders, today announced, a 1:8 reverse stock split of the Company's issued and outstanding common stock. The reverse stock split will become effective at 12:01, Eastern Time, on September 6, 2024, prior to the commencement of trading on the Nasdaq Capital Market.
LOS GATOS, CA / ACCESSWIRE / August 27, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon Medical" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced it has appointed Kevin Williamson as Chief Financial Officer. Mr. Williamson's appointment succeeds the previously disclosed retirement of Steve Van Dick from the role of Chief Financial Officer.
Tenon Medical, Inc. (NASDAQ: TNON) will be hosting their Q1 2024 Earnings Conference Call on May 14, 2024 at 4:30 PM ET. Presenting will be Steven M. Foster, the Chief Executive Officer, President and Director, along with Steven Van Dick, the Chief Financial Officer and Executive Vice President of Finance and Administration. Among the participants will be Bruce Jackson from The Benchmark Company and Anthony Vendetti from The Maxim Group. The call will begin with greetings from the operator.
Tenon Medical, Inc (TNON) Q4 2023 Earnings Call Transcript
LOS GATOS, CA / ACCESSWIRE / February 27, 2024 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacroiliac joint (SI Joint) disorders, today announced plans to release financial results for the fourth quarter and full year 2023 ended December 31, 2023 after market close on Tuesday, March 12, 2024. The Company will also hold a conference call the same day at 4:30 p.m.
What type of business is Tenon Medical?
Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
What sector is Tenon Medical in?
Tenon Medical is in the Healthcare sector
What industry is Tenon Medical in?
Tenon Medical is in the Medical Devices industry
What country is Tenon Medical from?
Tenon Medical is headquartered in United States
When did Tenon Medical go public?
Tenon Medical initial public offering (IPO) was on 27 April 2022
What is Tenon Medical website?
https://www.tenonmed.com
Is Tenon Medical in the S&P 500?
No, Tenon Medical is not included in the S&P 500 index
Is Tenon Medical in the NASDAQ 100?
No, Tenon Medical is not included in the NASDAQ 100 index
Is Tenon Medical in the Dow Jones?
No, Tenon Medical is not included in the Dow Jones index
When was Tenon Medical the previous earnings report?
No data
When does Tenon Medical earnings report?
Next earnings report date is not announced yet